HSBC Holdings’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.5K Buy
14,090
+2,568
+22% +$4.24K ﹤0.01% 2858
2025
Q4
$25.8K Hold
11,522
﹤0.01% 2894
2025
Q3
$18.8K Sell
11,522
-3,700
-24% -$7.74K ﹤0.01% 2675
2025
Q2
$39K Sell
15,222
-754
-5% -$2.97K ﹤0.01% 2950
2025
Q1
$104K Buy
15,976
+48
+0.3% +$340 ﹤0.01% 2799
2024
Q4
$108K Sell
15,928
-819
-5% -$5.39K ﹤0.01% 2879
2024
Q3
$137K Buy
16,747
+1,709
+11% +$12.4K ﹤0.01% 2731
2024
Q2
$92.8K Buy
+15,038
New +$116K ﹤0.01% 2744

Other funds holding LUNG

HSBC Holdings's LUNG Position: Q1 2026 in Review

HSBC Holdings increased its Pulmonx (LUNG) stake by 22% in Q1 2026, buying an estimated $4.24K and bringing the position to 14,090 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2858.

HSBC Holdings first reported a position in LUNG in Q2 2024 and has held it in 8 quarters since. The position peaked at $137K in Q3 2024. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • HSBC Holdings held 14,090 shares of Pulmonx worth $18.5K as of Q1 2026.
  • HSBC Holdings bought 2,568 Pulmonx shares in Q1 2026, an estimated $4.24K.
  • Pulmonx made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2858 holding.
  • HSBC Holdings first reported a position in Pulmonx in Q2 2024 and has held it in 8 quarters since.
  • HSBC Holdings's Pulmonx position peaked at $137K in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.